[playht_player width=”100%” height=”175″ voice=”Noah”]RespiraWorks, a nonprofit innovator of ventilators for developing countries, and Integrated Computer Solutions (ICS), creators of sophisticated embedded and touchscreen-enabled devices, announced a partnership to collaborate on RespiraWorks’ open-source ventilator. The medical-grade device, which can be assembled for under $500, is being designed for long-term vs. crisis use and for […]
Tag: COVID-19
Particle Physicists Develop New Vent for COVID-19 Use 🎧
[playht_player width=”100%” height=”175″ voice=”Noah”]In a little more than one month, from March 19 to May 1, the Mechanical Ventilator Milano (MVM) has gone from conception to reality, as it is now shifting to production and to support of patients affected severely by COVID-19. On May 1, 2020, the United States […]
ATS COVID-19 Crisis Fund Receives $100,000 from Gilead Sciences 🎧
Today, the American Thoracic Society announced a $100,000 donation from Gilead Sciences, Inc. to support the ATS COVID-19 Crisis Fund. This donation from Gilead is the latest in a highly appreciated increase in funding support from industry. The ATS COVID-19 Crisis Fund aims to develop and disseminate research, education and scientific recommendations […]
Clinicians Warn of the Dangers of Equating COVID-19 with High Altitude Pulmonary Edema
Early reports of COVID-19 symptoms and the compelling need to quickly identify treatment options and curb the growing number of critically ill patients have led to erroneous and potentially dangerous comparisons between COVID-19 and other respiratory diseases like high altitude pulmonary edema, or HAPE. In “COVID-19 Lung Injury and High […]
Were Ventilators Used Too Quickly to Treat COVID-19 Patients?
This week results from Sermo’s COVID-19 Real Time Barometer with over 5,900 physicians explored whether COVID-19 was a new type of disease, the controversial use of ventilators, as well as the new protocols that could change the way physicians treat COVID-19. In total, Sermo’s Barometer study includes over 27,000 survey […]
British Doctors Warn Some Chinese Ventilators Could Kill
Senior British doctors have warned that 250 ventilators the United Kingdom bought from China risk causing “significant patient harm, including death,” if they are used in hospitals, according to a letter seen by NBC News. The doctors said the machines had a problematic oxygen supply, could not be cleaned properly, […]
Remdesivir Phase 3 Trials in Patients With Severe COVID-19
Gilead Sciences, Inc. has announced topline results from the open-label, Phase 3 SIMPLE trial evaluating 5-day and 10-day dosing durations of the investigational antiviral remdesivir in hospitalized patients with severe manifestations of COVID-19 disease. The study demonstrated that patients receiving a 10-day treatment course of remdesivir achieved similar improvement in […]
International Study Suggests People With CF Have Lower COVID-19 Incidence
The Cystic Fibrosis Foundation announced data from a collaborative, international effort to understand the impact of COVID-19 on people with cystic fibrosis, a genetic disease that impacts the lungs and other organs. The manuscript, published in the Journal of Cystic Fibrosis, reports on 40 people with CF across eight countries […]
Recognizing a Fundamental Shift in Healthcare
By Rakhee Langer The rapid expansion of telehealth solutions illustrates the fundamental shift in thinking that has taken place among practices of all sizes and specialties. Understanding the changes in how providers and patients are learning and interacting today points to the role that digital solutions — specifically telehealth — […]
Itamar Funds Study to Evaluate Impact of CPAP Therapy on COVID-19 Patients
Study conducted at Mount Sinai Hospital in New York City designed to demonstrate benefit of continuous positive airway pressure (CPAP) in delaying or eliminating hospitalization and/or ventilation in patients with COVID-19 Study will also evaluate obstructive sleep apnea as a risk factor for hospitalization and ventilation in patients with COVID-19 […]













